The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

With flu infections starting to climb across Canada, doctors and public health specialists are preparing for a challenging influenza season. The concern centres on the global spread of a changing H3N2 strain that may not line up well with this year’s flu vaccine. Fresh federal figures released on Friday show that about two per cent of flu tests nationwide returned positive results last week. While that remains below the five per cent threshold Canada uses to officially declare a seasonal flu outbreak, it marks a clear rise compared to recent weeks.

Outside Canada, the current flu season has already been severe, with record case numbers reported in the Southern Hemisphere and an earlier-than-usual surge seen in parts of Asia and the United Kingdom. As winter approaches, experts say these trends could offer clues about what Canada might face. “This is the second year in a row that the Southern Hemisphere has seen higher-than-average influenza activity,” said Dr. Jesse Papenburg, a pediatric infectious disease expert at Montreal Children’s Hospital and the McGill University Health Centre, as per CTV News.

“When you look at case numbers, last year was likely the worst flu season Canada experienced in about ten years. Based on what we’re seeing so far, there’s a real possibility we could see a similar level of severity again,” he added.

Influenza A: What Is Leading To The Surge?

Some specialists believe a changing version of H3N2 is driving the early rise in cases. This form of influenza A is already known for causing more serious illness, particularly in older adults. What is raising extra concern this year is that recent mutations appear to be creating more distance between the circulating virus and the protection offered by the current flu shot. Dr. Danuta Skowronski, who leads influenza and emerging respiratory pathogen epidemiology at the B.C. Centre for Disease Control, is one of several Canadian experts closely tracking these changes, according to CTV News.

Influenza A: Experts Warn Of Vaccine Mismatch

Although the H3N2 subtype had remained relatively stable for years, Skowronski says it has recently begun showing sharper structural shifts as it spread into northern regions. These changes suggest the strain now circulating could be poorly matched to this season’s vaccine. The current flu shot is designed to protect against two influenza A strains, including H1N1 and H3N2, along with one influenza B strain. “There’s actually a fairly large gap between the H3N2 virus we’re seeing circulate and the one included in the vaccine,” Skowronski explained. “That’s not due to any error. It reflects how unpredictable and fast-changing influenza viruses can be.”

In a statement shared with CBC News, the Public Health Agency of Canada said it keeps close watch on respiratory virus trends around the world to identify patterns that could affect Canadians.

The agency also noted that flu data from the Southern Hemisphere does not always directly forecast what will happen in Canada, since seasonal patterns and population dynamics can differ.

“At this point, it’s still too early to say how severe Canada’s flu season will be,” the agency said, adding that factors such as which influenza subtype becomes dominant, the presence of other respiratory viruses, vaccine performance, and vaccination rates will all play a role.

Even if this year’s vaccine turns out to be less closely matched to the evolving H3N2 strain, all three experts emphasized that getting the flu shot remains important, especially for older adults across Canada.

U.S. health authorities have widened the approval of a closely debated medication designed to increase female libido, allowing the once-daily pill to be used by women over the age of 65. The decision, announced on Monday by the Food and Drug Administration, extends the drug’s use to older women who have already gone through menopause. The pill, Addyi, was originally cleared a decade ago for premenopausal women experiencing emotional distress linked to a low sex drive. Anisha Mathur, Founding Partner at Shepherd Law Associates, explained the development and what it means.

What Is Addyi?

Addyi, also known by its generic name flibanserin, is an FDA-approved prescription drug used to treat hypoactive sexual desire disorder, or HSDD, in women. HSDD refers to a long-term or recurring lack of sexual desire that leads to emotional distress or strain in relationships and cannot be explained by another medical condition, relationship difficulties, or medication side effects, according to the Cleveland Clinic.

Marketed by Sprout Pharmaceuticals, Addyi was once expected to become a major breakthrough in women’s health. However, the drug faced setbacks due to side effects such as dizziness and nausea. It also carries a strong safety warning about alcohol use. The FDA’s boxed warning, its strictest caution, notes that consuming alcohol while taking Addyi can lead to dangerously low blood pressure and fainting.

What Is Hypoactive Sexual Desire Disorder?

Hypoactive Sexual Desire Disorder, or HSDD, involves an ongoing reduction or absence of sexual thoughts, fantasies, and interest in sexual activity that causes significant personal distress or relationship tension. It is a common form of sexual dysfunction seen in both women and men. People with HSDD may experience low libido, little response to sexual stimulation, or a tendency to avoid sex altogether. Possible contributing factors include stress, relationship challenges, mental health conditions, certain medications, hormonal shifts, or past trauma.

The condition, which describes a distressing lack of sexual desire, has been recognised since the 1990s and is believed to affect a large number of women in the United States, based on survey data. After the commercial success of Viagra for men in the 1990s, pharmaceutical companies invested heavily in finding treatments for female sexual dysfunction. Diagnosis, however, remains complex because libido is influenced by many factors. After menopause, declining hormone levels bring biological changes and medical symptoms that further complicate assessment.

Addyi: FDA Approves Libido-Boosting Drug For Postmenopausal Women

U.S. health regulators have now expanded the approval of the controversial libido drug, allowing women over 65 to take the once-daily pill. The FDA’s announcement broadens its use to include older postmenopausal women.

According to CNN, diagnosing HSDD is challenging because sexual desire is affected by multiple physical, emotional, and psychological factors, particularly after menopause. Physicians are expected to rule out issues such as relationship stress, underlying medical conditions, depression, and other mental health disorders before prescribing the medication. The diagnosis itself remains debated, with some psychologists arguing that low sexual desire should not automatically be treated as a medical condition.

Before its approval in 2015, the FDA rejected Addyi twice, citing limited effectiveness and concerns over side effects. Its eventual approval followed a strong lobbying effort by the manufacturer and advocacy groups like Even the Score, which positioned the lack of treatment options for female libido as an issue of gender equality in healthcare.

Salad Dressing Recall: If you recently bought salad dressing or sauces, it may be time to double-check what’s sitting in your fridge following an important recall. On November 6, the U.S. Food and Drug Administration announced a recall covering thousands of gallons of dressings and condiments made by Ventura Foods LLC. The notice was later upgraded on December 4 to a Class II recall, highlighting the need to remove these products from stores and homes. Here is what consumers should know.

Also Read: The “Triangle of Death” on Your Face: Why You Should Never Pop a Pimple There

Salad Dressing Recall: What Products Are Being Recalled?

The expanded recall affects multiple Ventura Foods LLC products, including the following dressings and sauces:

• Caesar Dressing (Costco Food Court)—32 LB (14.51 kg); SKU: 0 26700 19376 7
• Caesar Dressing (Costco Service Deli)—23.62 LB (10.71 kg); SKU: 0 26700 19376 7
• Creamy Poblano Avocado Ranch Dressing and Dip—1 GAL (3.78L); SKU: 7 34730 53243 1
• Hidden Valley, Buttermilk Ranch—1 GAL (3.79L); SKU: 0 26700 19192 3
• Italian Salad Dressing—1 GAL (3.78L); SKU: 7 67367 00518 4
• Pepper Mill Creamy Caesar Dressing—1 GAL (128 FL OZ) 3.79 L; SKU: 0 93901 78134 5
• Pepper Mill Regal Caesar Dressing—1 GAL (128 FL OZ) 3.79 L; SKU: 0 93901 72607 0
• Publix Deli Carolina-Style Mustard BBQ Sauce—12 LB; SKU: 10 026700 16964 6
• Ventura Caesar Dressing—2000LB (907.1kg); SKU: 00 026700 17360 8

Costco also recalled two ready-to-eat items that used the affected dressing: the Caesar Salad (item number 19927) and the Chicken Sandwich with Caesar Salad (item number 11444). Both products are now past their sell-by dates, which ranged from October 17 to November 9, as per Health.

Salad Dressing Recall: Why Are Salad Dressings Being Recalled?

According to the FDA and Costco, the recalled dressings and sauces may contain pieces of plastic, described as “plastic foreign material,” leading to a voluntary recall. The FDA noted that because many of these products were manufactured in large quantities for food service use, they were likely supplied to delis, cafeterias, and similar facilities. Distribution covered 27 states, including Arkansas, Colorado, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Nebraska, New Hampshire, New Jersey, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Virginia, Washington, and Wisconsin.

Salad Dressing Recall: What Does A Class II Recall Mean?

On its website, the FDA explains that a Class II recall is its second most serious category. It refers to situations where using or being exposed to the product could cause temporary or medically reversible health effects, while the chance of severe health consequences is considered low.

Salad Dressing Recall: What Should I Do If I Purchased These Products?

The FDA has not issued detailed guidance for consumers who may have bought the recalled items. As with any recall, the safest step is to avoid consuming the products and contact the retailer for information about returns or refunds. Costco stated in its advisory that customers should stop using the affected items and bring them back to their local Costco location for a full refund.